A new RNA therapeutics platform for oncology

Cloverleaf’s Approach

Cloverleaf Bio is developing a new platform of engineered tRNA therapeutics to improve patient outcomes in oncology. Our technology allows for direct inhibition of up to 25 enzymes necessary for cancer growth from a single therapeutic molecule.